Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders??? Equity

v3.22.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 1,384 $ 75,890,295 $ 152,803 $ (37,473,580) $ 38,570,902
Balance (in Shares) at Dec. 31, 2019 13,846,925        
Common stock issued for cash (Note 13) $ 1 72,499 72,500
Common stock issued for cash (Note 13) (in Shares) 12,292        
Shares issued upon conversion of KBL debt (Note 11) $ 152 4,164,833 4,164,985
Shares issued upon conversion of KBL debt (Note 11) (in Shares) 1,519,628        
Shares issued upon conversion of 180 debt (Note 11) $ 48 2,117,270     2,117,318
Shares issued upon conversion of 180 debt (Note 11) (in Shares) 482,894        
Shares issued upon the conversion of the Series A convertible preferred stock (Note 13) $ 162 4,348,873     4,349,035
Shares issued upon the conversion of the Series A convertible preferred stock (Note 13) (in Shares) 1,619,144        
Shares issued upon exchange of common stock equivalents (Note 13) $ 153 (153)
Shares issued upon exchange of common stock equivalents (Note 13) (in Shares) 1,521,157        
Beneficial conversion feature on convertible debt issued (Note 11) 329,300 329,300
Deemed dividend on Series A convertible preferred stock (Note 13):          
Extinguishment loss (565,659) (565,659)
Make-whole dividend $ (333,333) $ (333,333)
Beneficial conversion feature (in Shares) (223,710) (223,710)
Stock based compensation (Note 13):          
Common stock $ 24 $ 1,057,965 $ 1,057,989
Common stock (in Shares) 240,540        
Options 7,798 7,798
Effect of reverse recapitalization, net of cash acquired (Note 4) $ 693 (8,860,974) (8,860,281)
Effect of reverse recapitalization, net of cash acquired (Note 4) (in Shares) 6,928,645        
Comprehensive income (loss):          
Net loss (10,884,058) (10,884,058)
Other comprehensive income (loss) 484,083 484,083
Balance at Dec. 31, 2020 $ 2,617 78,005,004 636,886 (48,357,638) 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Shares issued upon conversion of KBL debt (Note 11) $ 47 1,941,078 1,941,125
Shares issued upon conversion of KBL debt (Note 11) (in Shares) 467,123        
Shares issued upon conversion of 180 debt (Note 11) $ 16 432,367 432,383
Shares issued upon conversion of 180 debt (Note 11) (in Shares) 158,383        
Deemed dividend on Series A convertible preferred stock (Note 13):          
Shares issued in connection with the financing, net of financing costs (Note 9) $ 256 10,730,814 10,731,070
Shares issued in connection with the financing, net of financing costs (Note 9) (in Shares) 2,564,000        
Offering costs allocated to warrant liabilities (Note 13) 604,118 604,118
Warrants issued in connection with private offering, reclassified to derivative liabilities (Note 9) (7,294,836) (7,294,836)
Shares issued upon exchange of common stock equivalents (Note 13) $ 174 (174)
Shares issued upon exchange of common stock equivalents (Note 13) (in Shares) 1,745,054        
Shares issued to settle accounts payable (Note 12) $ 23 1,973,227 1,973,250
Shares issued to settle accounts payable (Note 12) (in Shares) 225,000        
Shares issued in connection with the August 2021 Offering, net of financing costs (Note 13) $ 250 13,879,750 13,880,000
Shares issued in connection with the August 2021 Offering, net of financing costs (Note 13) (in Shares) 2,500,000        
Shares issued to settle convertible debt and derivative liabilities with Alpha Capital (Note 11) $ 15 1,060,485 1,060,500
Shares issued to settle convertible debt and derivative liabilities with Alpha Capital (Note 11) (in Shares) 150,000        
Shares issued in connection with the repayment of related party loans and convertible notes (Note 13) $ 15 851,097 851,112
Shares issued in connection with the repayment of related party loans and convertible notes (Note 13) (in Shares) 141,852        
Stock based compensation (Note 13):          
Common stock $ 31 2,148,858 2,148,889
Common stock (in Shares) 317,553        
Options 2,852,309 2,852,309
Shares Cancelled $ (40) 40
Shares Cancelled (in Shares) (404,265)        
Comprehensive income (loss):          
Net loss (20,324,648) (20,324,648)
Other comprehensive income (loss) 180,554 180,554
Balance at Dec. 31, 2021 $ 3,404 $ 107,184,137 $ 817,440 $ (68,682,286) $ 39,322,695
Balance (in Shares) at Dec. 31, 2021 34,035,925